The pathophysiological analysis of abnormal growth hormone signaling

The pathophysiological analysis of abnormal growth hormone signaling - Analysis of growth hormone signaling

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000009931

Enrollment

200

Registered

2013-02-01

Start date

2012-07-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients with short stature, tall stature, acromegaly, or gigantism, patients without these diseases as a control

Interventions

A hundred cases of patients with short stature, tall stature, acromegaly, and gigantism, 100 cases of control patients. This could be changed with appropriate modification procedure. This study will

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: The patients with short stature, tall stature, acromegaly, and gigantism, or patient without these diseases as a control, who agreed with the study.

Exclusion criteria

Exclusion criteria: 1) the patients who refused to the study 2) the patients who were redarded as inadequate by doctor

Design outcomes

Primary

Measure	Time frame
Novel gene mutation related to abnormal growth hormone signaling	—

Countries

Japan

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026